AiCuris starts pilot trial with proprietary immunomodulator AIC649, a unique therapy to prevent severe symptoms in SARS-CoV-2 infections

Newron announces Half-Year 2021 results

Temedica develops new digital companion Brisa for people with multiple sclerosis in cooperation with Roche

Abivax provides an update on the ABX464 clinical data and development strategy in ulcerative colitis

RedHill Biopharma Accelerates Ongoing U.S. Phase 2/3 COVID-19 Study of Once-Daily Oral RHB-107 in Non-Hospitalized Patients with South African Approval

Adocia To Participate in the H.C. Wainwright 23rd Annual Global Investment Conference

Marinomed Biotech AG publishes clinical data on efficacy of Carragelose lozenges against respiratory viruses including SARS-CoV-2 in the International Journal of General Medicine

EsoCap – unique targeted application platform to treat the upper gastrointestinal tract

InflaRx to Proceed with Pivotal Development for Vilobelimab in Hidradenitis Suppurativa with New Primary Endpoint

Diaccurate Acquires Clinical Stage Sole-in-Class Targeted Cancer Therapy from Merck